Incyte (NASDAQ:INCY) Delivers Strong Q1 Numbers - Yahoo Finance
3 weeks ago • Google News
Incyte Corporation (INCY)
US$ 58.98-1.26%
Price Chart
Key Statistics
Market Cap
$ 12.35B
P/E Ratio
319.05
Revenue (TTM)
$ 4.41B
Volume
1.23M
52W High
$ 83.95
52W Low
$ 53.56
Dividend Yield
0.00%
Beta
0.68
Technicals
50-Day MA
61.0704
200-Day MA
67.31
52 Week High
83.95
52 Week Low
53.56
About INCY
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI.
Employees
2617
Headquarters
Wilmington, DE
CEO
Mr. Herve Hoppenot
Latest News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
29.4
Percentile: 47.86
Environmental Risk Score
7.61
Percentile: 8
Social Risk Score
24.73
Percentile: 8
Governance Risk Score
12.56
Percentile: 8
Controversy Level
ESG data provided by Sustainalytics, Inc.
INCY
Category Average
1Low Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg